Who Paid My Doc
William Fillmore
Oral & Maxillofacial Surgery Rochester, MN Doctor of Dentistry
NPI 1336397587 CMS profile 1255198
200 1St St Sw, Rochester, MN 55905
General payments
$39
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, William Fillmore of Rochester, MN is reported in the CMS Open Payments database as having received $39 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 6th percentile of Oral & Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $39 | 1 |
Beside peers
- William Fillmore
- Oral & Maxillofacial Surgery median
- Middle half of Oral & Maxillofacial Surgery
- National median
In program year 2025, general payments to William Fillmore were reported at $0. Among 792 Oral & Maxillofacial Surgery profiles paid that year, the median was $184 and the middle half received between $61 and $541.
Show as a table
| Year | William Fillmore | Oral & Maxillofacial Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $178 | $56–$584 | $163 |
| 2020 | $0 | $106 | $38–$316 | $114 |
| 2021 | $0 | $165 | $57–$511 | $132 |
| 2022 | $0 | $173 | $63–$494 | $149 |
| 2023 | $0 | $184 | $62–$521 | $160 |
| 2024 | $39 | $197 | $65–$603 | $164 |
| 2025 | $0 | $184 | $61–$541 | $169 |
Breakdown
Billing to Medicare
Part B · data year 2024 · 35 billing codesPaid by Medicare
$29,653
Medicare patients
104
Services billed
403
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 59% | |
| Arthritis | 51% | |
| Chronic kidney disease | 30% | |
| Depression | 30% | |
| Heart failure | 18% | |
| Osteoporosis | 18% | |
| Atrial fibrillation | 16% | |
| Diabetes | 15% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 | Office | 11 | 34 | $20 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Oral & Maxillofacial Surgery in Minnesota
James Swift
Oral & Maxillofacial Surgery · Minneapolis, MN
Kevin Rieck
Oral & Maxillofacial Surgery · Rochester, MN
Christopher De La Mater
Oral & Maxillofacial Surgery · Coon Rapids, MN
Dane McMillan
Oral & Maxillofacial Surgery · Rochester, MN
Kevin Arce
Oral & Maxillofacial Surgery · Rochester, MN
Joshua Bednar
Oral & Maxillofacial Surgery · Coon Rapids, MN
Related records
Oral & Maxillofacial Surgery in Minnesota
Practitioners in the same specialty and state, ranked by reported value.
All Oral & Maxillofacial Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Minnesota
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.